Key facts
- This page summarizes Erin Mistry's Form 4 filing for CorMedix Inc. (CRMD).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 14 Jan 2025, 19:14.
Erin Mistry - 10 Jan 2025 Form 4 Insider Report for CorMedix Inc. (CRMD)
- Reporting relationship
- EVP, Chief Commercial Officer
- Issuer ticker
- CRMD
- Reported as of
- 10 Jan 2025
- Net transaction value
- -$63,660
- SEC form
- 4
- Accepted by SEC
- 14 Jan 2025, 19:14:59 UTC
- Prior SEC filing
- 06 Jan 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Erin Mistry
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Erin Mistry filed Form 4 for CorMedix Inc. (CRMD) on 14 Jan 2025.
Change
- Previous filing in this sequence was filed on 06 Jan 2025.
- Current net transaction value: -$63,660.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRMD
transaction
Common Stock
Tax liability
- Transaction value
- $63,660
- Shares
- -5,689
- Change %
- -5.3%
- Price
- $11.19
- Shares after
- 100,992
- Date
- 10 Jan 2025
- Ownership
- Direct
* marks a reported price that did not pass the local price check.